Adma Biologics
(NASDAQ) ADMA
Adma Biologics Financials at a Glance
Market Cap
$2.07BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$509.86M
Net Income (TTM)
$165.35M
EPS (TTM)
$0.68
P/E Ratio
13.20
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$9.15
Volume
72,214
Open
$8.94
Price
$9.15
Volume
72,214
Open
$8.94
Previous Close
$9.15
Daily Range
$8.85 - $9.15
52-Week Range
$7.21 - $20.46
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$9.15
Volume
72,214
Open
$8.94
Previous Close
$9.15
Daily Range
$8.85 - $9.15
52-Week Range
$7.21 - $20.46
Estimated Earnings Date
Aug 5, 2026
ADMA News
ADMA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Adma Biologics
Industry
Biotechnology
Sector
Health CareEmployees
647
CEO
Adam S. Grossman
Website
www.admabiologics.comHeadquarters
Ramsey, NJ 07446, US
ADMA Financials
Key Financial Metrics (TTM)
Gross Margin
61.27%
Operating Margin
40.57%
Net Income Margin
32.43%
Return on Equity
38.97%
Return on Capital
34.36%
Return on Assets
24.86%
Earnings Yield
7.58%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.07BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
231.77M
Volume
72.21K
Avg. Volume
5.23M
Financials (TTM)
Gross Profit
$312.42M
Operating Income
$206.86M
EBITDA
$221.54M
Operating Cash Flow
$128.32M
Capital Expenditure
-$20.42M
Free Cash Flow
$107.90M
Cash & ST Invst.
$138.15M
Total Debt
$204.41M
Adma Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$114.49M
-0.3%
Gross Profit
$80.75M
+32.2%
Gross Margin
70.53%
N/A
Market Cap
$2.07BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$3.03M
N/A
Employees
685
N/A
Net Income
$45.33M
+68.5%
EBITDA
$61.07M
+63.3%
Quarterly Fundamentals
Total Cash
$138.15M
+92.9%
Total Debt
$204.41M
+149.2%
Accounts Receivable
$135.86M
+36.7%
Inventory
$222.10M
+29.0%
Long Term Debt
$199.95M
+147.4%
Short Term Debt
$4.46M
+275.2%
Return on Assets
24.86%
N/A
Return on Invested Capital
34.96%
N/A
Free Cash Flow
$55.71M
+328.5%
Operating Cash Flow
$58.25M
+396.1%